alexa Bioprospecting of Uncultured Microorganisms: The Dawning of Antibiotic Discovery | Open Access Journals
ISSN: 2327-5073
Clinical Microbiology: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Bioprospecting of Uncultured Microorganisms: The Dawning of Antibiotic Discovery

Zhi-Qiang Xiong*

School of Medical Instrument and Food Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China

*Corresponding Author:
Zhi-Qiang Xiong
School of Medical Instrument and Food Engineering
University of Shanghai for Science and Technology
Shanghai 200093, China
Tel.: +86-21-55803272
E-mail: [email protected]

Received Date: January 28, 2016 Accepted Date: February 01, 2016 Published Date: February 08, 2016

Citation: Xiong ZQ (2016) Bioprospecting of Uncultured Microorganisms: The Dawning of Antibiotic Discovery. Clin Microbiol 5: e132. doi: 10.4172/2327-5073.1000e132

Copyright: © 2016 Xiong ZQ. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Clinical Microbiology: Open Access

Editorial

Antibiotics are of great benefit for human health such as using in pathogenic infection, organ transplantation, cancer treatment and cholesterol control [1]. But a huge threat of global public health caused by multi-drug-resistance pathogens (e.g., gram-positive methicillin and vancomycin resistant Staphylococcus aureus and New Delhi metallo-beta-lactamase 1 gram-negative bacteria) has emerged extensively [2]. Despite this threat has ever-increasing public awareness regarding “superbug” infections, treatment options, unfortunately, continued to be limited [3]. The discovery of new antibiotics is one of direct action on the treat of drug resistant pathogenic infections for avoiding an epidemic [2]. However, the pace of antibiotic discovery and development with unique scaffold is dramatically declining after the past 60 years of intensive screening [4], especially the collapse of the antibiotic discovery pipeline that the last new class of antibiotics daptomycin discovered in 1987 has been successfully developed into a clinical therapeutic [5]. Currently, all microorganism derived commercial antibiotics come from cultivated species, especially five phyla Actinobacteria, Bacteroidetes, Cyanobacteria, Firmicutes, and Proteobacteria that represent 95% of antibiotic-producing microbes [6]. Because uncultured microorganisms are approximately 99% of microbial species, a recent trend in antibiotic discovery from natural sources emphasizes the investigation of uncultured microorganisms (do not grow under laboratory conditions) to meet the urgent demand for novel drug.

Uncultured microorganisms cannot be cultured by traditional culture techniques [4,7], developing cultivation methods of uncultured microorganisms thus play a key role for systematic investigation of the previously inaccessible antibiotics with interesting biological activities. Some novel technologies and cultivation methods (iChip [7], highthroughput extinction culturing [8,9], diffusion chamber [10], single cell encapsulation combined with flow cytometry [11], coculture [12], microbial culture chip [13], filtration-acclimatization [14], double encapsulation [15], micromanipulator [16], optical tweezers [17], transwell plates [18], and community culture [19]) have been exploited for isolation and cultivation of uncultured microorganisms. Despite these techniques have significant effect on isolation and culture of uncultivated microorganisms, new approaches and techniques are still required for recovering more uncultivated microbial species to discover the structurally unique antibiotics.

Pure culture may be the only way to comprehensive characterization of physiological properties and full assessment of application potential of individual microbial species [20]. I believe, with the development of the large-scale cultivation strategies of the uncultured majority of the microbial world, bio-prospecting of uncultured microbes could be a shortcut to discover novel antibiotics that is a perpetual need to combat new diseases and drug-resistant pathogens for public health [3,7]. Uncultured microbes have recently been reported to produce a new cell wall inhibitor teixobactin that kills pathogens without detectable resistance [7] and other diverse natural products [21], which could be a new dawning of antibiotic discovery. Uncultivated microorganisms will be better understood and discovered in the next decade by a combination of both conventional and innovative techniques. Thus, bio-prospecting of uncultivated microorganisms has a great application potential for the discovery of antibiotics with unique scaffolds and for exploitation in the pharmaceutical and agricultural industries.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 8204
  • [From(publication date):
    February-2016 - Sep 22, 2017]
  • Breakdown by view type
  • HTML page views : 8057
  • PDF downloads :147
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords